The enhancing effects of stroma on AML differentiation have been reported in AML cells carrying internal tandem duplication-FLT3 (ITD-FLT3) in response to gilteritinib (Sexauer et al., 2012). The gene discussed is FLT3; the disease is acute myeloid leukemia.